{"name":"Blade Therapeutics","slug":"blade-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxOOGhDYjBKcUZXZGY0SmRFLWlXYWdxWDJFa1NFY2hGZE5IcUxTSlNYZkJUenNNTGpjSnhqMHM1RmJmaTVNZVN5WjRzY2N6a1ZqRnZzN3F0QTBUdzdQMzVxVkNsSEg2V3pQYWJBTHBsTzVxdHNaaHpoaXdrVUw0Tm00SEtHeks3YXVDSUF1blZSV2t5bVBXTlYtelFyclIxcGU2WUFzTTFNN09kd1JKbkhYaVVUSVZuT292TnEtbTJ5Tm9Ta0NONDFoYkxLUlF0UUNDUEs1V25xVHFyRzVjSVhaMVJFeTMteEFBNGFPVnNBYUswNHYzc0tEVzV4akNsakZIRGVrTUx2Z0d0WGNLY1g3SW41SVc2ckg3djVTVmNRQUxZQ0NpSi14RTN1cDk2ZnRZY1FlZjBRSnh1ZUpOS0ptMF9VY2Z2VlcwYm84WmhpOA?oc=5","date":"2026-04-03","type":"pipeline","source":"Barchart.com","summary":"Multiple System Atrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Brain Neuro -","headline":"Multiple System Atrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ionis Pharma, Biohaven ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxPSXIwNlY4QXpwM1pSTThkajRZenBRWVFPMkVhYW45TkNVX2F3bUlFRFkyQmNTaHpPYy1xdlZTWXk2bHlJNkdNY3ZtR0hzb0NDbzFfMzBlRG5fUnhVSkxYU2lvNFpXM0FIWDNKWk9xWW1wR19qTFJUZExFOXZrdTVHbnVzNC1EemlkWnE2WXl0b0tnS1d5bjRsSWR3cVh4cnZ2Q2dRVVo3SXNLMC11dmJzWjRDeG1GY0FHdGtFNVVTcFNKZ09uNDVZWDl3RlVqdk5lSVJiSkdfbUY3bUUxQlJZLVhQaXZ2dzZLTzFWaXZwbkpCM2U4OThFU1JMSElnWE1ZTnc?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"Systemic Sclerosis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com","headline":"Systemic Sclerosis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxOSjZfc2JwRHlsNFp6cXoybWN4LXc3VWZZVE1QQ2RjYkdfUnRGbHNXVEpCSGplcG1SVWZuWHJxMjM2c0NOTTJwODRzSXhsRTFzTmkydE8za1ZmTC1neEdhV3IyYTg4cmtZTjI4aWc0UGd3RUMzWTBQTUVfc05sOHQ0cmJnUTZzX21UU0d0Y1A1cG85TlBqQk1IUG1pRUhPMFBrUW01NjB2cUxidlM5d2NQTFZvOTJ4VkptQ1dtZndHRjMzUEJvME5STkhUOUFXWWJkdnBuczl4Wld5dkFyTndicHh6RXJ4VFNIdWhqRWV2bzFEbzBTTF9xeWc4UFhDZV80MFRGSS1tT0hweGFVZWVxWVpXQURBUlRKOFZTY2lYbTJRNHZVY3RPSGJnc2RGbUJtNHdSMU9hNjh5MHNpUFN4SA?oc=5","date":"2026-03-03","type":"pipeline","source":"GlobeNewswire","summary":"T-knife Therapeutics Announces Authorization of Clinical - GlobeNewswire","headline":"T-knife Therapeutics Announces Authorization of Clinical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPTjNSX3FuQ3VKaUhNRWZJNzlsM3c4Y2RQUGV6RUcyQm0xdUFXYzdIZFdvX2FkSTk1dW44S0JoeWtDUENvS0Vta0ZNekZ2WmpWSWJ6X1hVVnl0bXBDcVpEa3AwMzVOdEoyc1FhQ2w2U0Z5YnhhU3Z6NVNoVEpFa1ZiUEU0M004OWozN2pUT29NMWZvTkdQUWRiZ1AwV0JHX0kxMWpWX1JpQU1kdkpIODhTUU1YLVZqX0dQM3pfRnQxV3Q?oc=5","date":"2026-03-02","type":"pipeline","source":"Contract Pharma","summary":"3T Biosciences Taps Rebeca Villarreal-Barragan as Head of Clinical Operations - Contract Pharma","headline":"3T Biosciences Taps Rebeca Villarreal-Barragan as Head of Clinical Operations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPdnJYbUFOdEl5LUNtUHdFOGJHX2dEWmZWdkpBYjZka1JCaUxHX3FWeEhJRDZxbG9pWnRFR0ZWVXZOMXlrVnRzSDV4dXJXRkNmUW1DcFZpWWtxMjhjZnB5TDFoakpWRDBRandYdGVjV01CblNIYUZPLVlBYzhDYjR0SjBpc0h0QUs5TWdqakZ4Z0F0cUlweWc?oc=5","date":"2026-02-03","type":"pipeline","source":"Contract Pharma","summary":"Spruce Biosciences Makes Two SVP Appointments - Contract Pharma","headline":"Spruce Biosciences Makes Two SVP Appointments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNeE5EdlFUQ1BvTnc1dmJLRExQWEV6SThXQkxlcWQ5NFAzQmRPd3h3X3RWY3NhVEtnT1AyLVBGOVAxWUJoOEZsb0R0Q1Z0SGNIeVgxVjJIRE5qMGZaSWs3cWFPc0UzaUtIMW9oTjN1QWgxc0tqZGdCenl4c2tWUjlQZHhpTjN1RXNfeTJzTW1uMEc2bTZoTW1jOTY0Z3k3OTloMzVaMXFPOVJiQWdqSWtoWGZOeWkwajNDMzBBMjBIb04zUFhHamRIMU43YlBNd1UzWWJJQm1xNGY0dkJNZVE?oc=5","date":"2026-02-03","type":"regulatory","source":"businesswire.com","summary":"Spruce Biosciences Adds Regulatory and Clinical Development Expertise to Leadership Team - businesswire.com","headline":"Spruce Biosciences Adds Regulatory and Clinical Development Expertise to Leadership Team","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxONzdUTEhZRUVqVUI1T2dwZ0RRR1VqLURDUHNoU25fQmxwWUFLR1lwM0pyWjJVYU16Nkh6RHJTc251V3p3bkFVSzFyd1YzeHE5Q041dGd4M081TmtsYlFHX05HN2h4X2lwZTIxZGtVRGItdHRpWlpHZGJTNnVHQ2tJZlZmVkZBYjBoVktzaXFuVUNzNExicXc?oc=5","date":"2026-01-23","type":"pipeline","source":"statnews.com","summary":"Up and down the ladder: The latest comings and goings - statnews.com","headline":"Up and down the ladder: The latest comings and goings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxQOG1WWUw4VEJlenF5T05oZXF5YTlLS1BVczlfUDkzRGQxbWFnRHJCY3FmMmhnVlAyQ1R1MHdtcUZLbjMtai1oZEl5bk5uSXBvQkpPRjEtVnRKV01jQVVWOWNaWTVVWENma1gxR19fSlJNOEJwSGRwTWRvNllTTU8tNzZjWF9ySGVodFd2NmFiTTBOMWMyQThIT3ZDVk1YYmp1WnpfaEZJa193X3YtVXdMcU93cVh1Q0lOV1kzUUFQMTBMcm4wWHBmMUtrTkJ3V2NiNE5ZRlVha3BnWERUT2lCUEdxY1JDMUI1ZV8yWGJ0aGxndFVrWlFuOWhyMkRpTHc?oc=5","date":"2026-01-16","type":"pipeline","source":"TradingView","summary":"SpyGlass Pharma, Sustained-Release Ophthalmic Drug-Delivery Company, Files for Nasdaq Global Select Market IPO - TradingView","headline":"SpyGlass Pharma, Sustained-Release Ophthalmic Drug-Delivery Company, Files for Nasdaq Global Select Market IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPUkRyZVRUQU8ybFZTNjRIS0FGbFQ4SkN2eld5S2g1ZkVuckkzdXMybnl4Q2x0Q0ZOQXdfYm1zMnBDTzZjaEFTNUxTVWZRdkpnekt2OWx5d0U4bkdwRlZuMmRkWmw0eFVNamtsbk9RbDJMVjFYUDVzWXQ0b0laN0xkeVp3UGhlbWR3MFNXbzktQWtEa2FBMVZuMy1vUkgzMTBocG5TQVAyTkJKOUNTTU9LRmkzWQ?oc=5","date":"2026-01-09","type":"trial","source":"endpoints.news","summary":"Viking gets commercial chief while other obesity biotechs sell; Novo’s Uli Stilz steps down - endpoints.news","headline":"Viking gets commercial chief while other obesity biotechs sell; Novo’s Uli Stilz steps down","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNRGJvY2tPSTlMZGdEdWc5NEE0R0w4cG5ZTlZaZzdTUE10aF9hMW4xSlR4a0xib29SSHVleTBKSHM2ZzhwM05mTzZxZzdzMlEzYXJjbzJPemwySE9tM01aLWJtZC1xTjNqamRCSExpMnY1eHJvdVl0NUUya3ltbkV1YldYcVl1S0FrcXdVZHN0c0VSaGNvQ0JxcFZNMUJqMlZNR2ltZ1NjNFdlbi02U1Z1SA?oc=5","date":"2026-01-06","type":"pipeline","source":"BioSpace","summary":"SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer - BioSpace","headline":"SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNMEJGQjFVZzdVQm5lbDZVS1dLTnY3Q1I5YVp1bFdSTDFuaDZWZElpaDEyREk3XzdqcEVZaE9jd3drWUxYdzB3MTVFVDdtSHhPR09DX2ItOTVyYXl6QU92aFY0WnV4NVdIQ2FDUDhwVXl0WFhxYUVuRzV6T1FJT21ZcVlWM3p1cVpLdGpqbUNtanFrOUVBQ2l0dGJ6Rm9TNHc?oc=5","date":"2025-11-13","type":"deal","source":"Yahoo Finance","summary":"Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger - Yahoo Finance","headline":"Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNN2w4LTA1VzI4cU5DanB0WUcwXzdvUDdNblZSTlFEZE9SUFZ0bEduRnA5dWxpeWp0TlNEcWpYeURQVXNqeG94NFNqeUdILWtoVGxMdDlncEJIVVdsSHFNTmRwYmd6eHpYUEp3N3VpaEJKZXk0dW9mVHlIM2oyNE5MeENZcUluUkJDSF9MelFmSW01REJCRHNhQlI4dUR4c3NTV3E2d3VodXVvTm0xVzUtWm1wQQ?oc=5","date":"2022-06-13","type":"deal","source":"Fierce Biotech","summary":"Another biotech SPAC bites the dust as Blade Therapeutics' planned merger is canceled - Fierce Biotech","headline":"Another biotech SPAC bites the dust as Blade Therapeutics' planned merger is canceled","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}